What does APOTHEEK VERSCHAEVE do?

APOTHEEK VERSCHAEVE is a pharmacy in Poperinge. Private Limited, started on 21 June 2006, 1 establishment.

What is the address of APOTHEEK VERSCHAEVE?

The registered office of APOTHEEK VERSCHAEVE is located at Zevekotestraat 15, 8970 Poperinge.

Is APOTHEEK VERSCHAEVE still active?

Yes. According to the CBE (29 October 2026) APOTHEEK VERSCHAEVE is active, legal situation “Normale toestand”, started on 21 June 2006.

Is APOTHEEK VERSCHAEVE registered on Peppol?

Yes, APOTHEEK VERSCHAEVE is registered on the Peppol network with ID 0208:0881982693.

What is the enterprise number of APOTHEEK VERSCHAEVE?

The enterprise number of APOTHEEK VERSCHAEVE is BE0881982693.

When was APOTHEEK VERSCHAEVE founded?

APOTHEEK VERSCHAEVE was founded on 21 June 2006.

Who are the directors of APOTHEEK VERSCHAEVE?

According to the 2025 annual accounts, the directors of APOTHEEK VERSCHAEVE are: Kathleen VERSCHAEVE.

Is APOTHEEK VERSCHAEVE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 June 2006; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK VERSCHAEVE make in 2025?

APOTHEEK VERSCHAEVE recorded a loss after taxes of € 4,823 in financial year 2025.

What is the revenue of APOTHEEK VERSCHAEVE?

As a small company, APOTHEEK VERSCHAEVE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 110,929.

Does APOTHEEK VERSCHAEVE have a website?

Yes, APOTHEEK VERSCHAEVE has a website at apotheekverschaeve.be.

APOTHEEK VERSCHAEVE (Private Limited) - Poperinge

Dossier APOTHEEK VERSCHAEVE, printed on 29 October 2026 from databakkes.be/en/0881982693/apotheek-verschaeve. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VERSCHAEVE from Poperinge, company number BE0881982693, closed financial year 2025 with a result of € -4,823 after tax. For that financial year APOTHEEK VERSCHAEVE recorded a gross margin of € 110,929 and equity of € 448,162. Compared with financial year 2024, the result moved from € 55,127 to € -4,823. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 15, 2025.

What it is worth Healthy

€ 448,162

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -4,823

▼ still € 55,127 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 186,939

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 428,162.

People and assets in 2025

Wage cost

€ 73,241

▲ 93% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 14,308

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 24,119

▼ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,796

▼ 21% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 289,883 Gross margin 2022: € 289,883 First fiscal year in the series	€ 168,863 Gross margin 2023: € 168,863 ▼ 42% vs 2022 (€ 289,883) Unfavourable step	€ 131,007 Gross margin 2024: € 131,007 ▼ 22% vs 2023 (€ 168,863) Unfavourable step	€ 110,929 Gross margin 2025: € 110,929 ▼ 15% vs 2024 (€ 131,007) Unfavourable step	▼ 15%
Profit after taxes	€ 142,083 Profit after taxes 2022: € 142,083 First fiscal year in the series	€ 81,422 Profit after taxes 2023: € 81,422 ▼ 43% vs 2022 (€ 142,083) Unfavourable step	€ 55,127 Profit after taxes 2024: € 55,127 ▼ 32% vs 2023 (€ 81,422) Unfavourable step	€ -4,823 Profit after taxes 2025: € -4,823 ▼ € 59,950 vs 2024 (€ 55,127) Unfavourable step	▼ € 59,950
Equity	€ 520,951 Equity 2022: € 520,951 First fiscal year in the series	€ 435,814 Equity 2023: € 435,814 ▼ 16% vs 2022 (€ 520,951) Unfavourable step	€ 488,408 Equity 2024: € 488,408 ▲ 12% vs 2023 (€ 435,814) Favourable step	€ 448,162 Equity 2025: € 448,162 ▼ 8% vs 2024 (€ 488,408) Unfavourable step	▼ 8%
Total debts	€ 194,789 Total debts 2022: € 194,789 First fiscal year in the series	€ 263,747 Total debts 2023: € 263,747 ▲ 35% vs 2022 (€ 194,789) Unfavourable step	€ 171,010 Total debts 2024: € 171,010 ▼ 35% vs 2023 (€ 263,747) Favourable step	€ 191,996 Total debts 2025: € 191,996 ▲ 12% vs 2024 (€ 171,010) Unfavourable step	▲ 12%
Cash	€ 171,979 Cash 2022: € 171,979 First fiscal year in the series	€ 192,188 Cash 2023: € 192,188 ▲ 12% vs 2022 (€ 171,979) Favourable step	€ 222,212 Cash 2024: € 222,212 ▲ 16% vs 2023 (€ 192,188) Favourable step	€ 186,939 Cash 2025: € 186,939 ▼ 16% vs 2024 (€ 222,212) Unfavourable step	▼ 16%
Land & buildings	€ 12,274 Land & buildings 2022: € 12,274 First fiscal year in the series	€ 10,044 Land & buildings 2023: € 10,044 ▼ 18% vs 2022 (€ 12,274) Unchanged	€ 7,813 Land & buildings 2024: € 7,813 ▼ 22% vs 2023 (€ 10,044) Unchanged	€ 5,582 Land & buildings 2025: € 5,582 ▼ 29% vs 2024 (€ 7,813) Unchanged	▼ 29%
Retained profit	€ 500,951 Retained profit 2022: € 500,951 First fiscal year in the series	€ 415,814 Retained profit 2023: € 415,814 ▼ 17% vs 2022 (€ 500,951) Unfavourable step	€ 468,408 Retained profit 2024: € 468,408 ▲ 13% vs 2023 (€ 415,814) Favourable step	€ 428,162 Retained profit 2025: € 428,162 ▼ 9% vs 2024 (€ 468,408) Unfavourable step	▼ 9%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 166,558 Dividend 2023: € 166,558 ▲ € 165,758 vs 2022 (€ 800) Unchanged	€ 2,533 Dividend 2024: € 2,533 ▼ 98% vs 2023 (€ 166,558) Unchanged	€ 35,424 Dividend 2025: € 35,424 ▲ € 32,891 vs 2024 (€ 2,533) Unchanged	▲ € 32,891
Bank debt	€ 8,848 Bank debt 2022: € 8,848 First fiscal year in the series	€ 684 Bank debt 2023: € 684 ▼ 92% vs 2022 (€ 8,848) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 684) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 715,740 Balance sheet total 2022: € 715,740 First fiscal year in the series	€ 699,561 Balance sheet total 2023: € 699,561 ▼ 2% vs 2022 (€ 715,740) Unchanged	€ 659,418 Balance sheet total 2024: € 659,418 ▼ 6% vs 2023 (€ 699,561) Unchanged	€ 640,158 Balance sheet total 2025: € 640,158 ▼ 3% vs 2024 (€ 659,418) Unchanged	▼ 3%

Key figures of APOTHEEK VERSCHAEVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 December 2026.

What happened to APOTHEEK VERSCHAEVE?

What happened at APOTHEEK VERSCHAEVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 15, 2025 New annual accounts for financial year 2025: loss of € 4,823 (▼ € 59,950 vs 2024). Source: NBB ↗
Jul 1, 2006 New establishment in Poperinge. KBO
Jun 21, 2006 Start of the company according to the CBE. KBO

In short

From € 142,083 profit in 2022 to € 4,823 loss in 2025.

Paid € 131,716 in corporate taxes since 2022.

Best year ever: 2022, with € 142,083 profit.

Paid out € 205,315 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Kathleen VERSCHAEVE

APOTHEEK VERSCHAEVE

Behind APOTHEEK VERSCHAEVE is Kathleen VERSCHAEVE.

Directors

According to the 2025 annual accounts

Kathleen VERSCHAEVE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Zevekotestraat 15

8970 Poperinge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

KPL & C°

€ 112,592 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekverschaeve.be

Technologies

AWS S3BootstrapChart.jsCloudflare CDNDiviElementorFacebook PixelFont AwesomeGoogle FontsOwl CarouselPHPSwiperWP RocketWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages EN

Features

Webshop Blog Ads Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0881.982.693

VAT number

BE 0881.982.693

Registered office

Zevekotestraat 15, 8970 Poperinge

Names & denominations

APOTHEEK VERSCHAEVE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 June 2006

Peppol

Active · Active since 3 Dec 2025

Contact

apotheekverschaeve.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VERSCHAEVE

Financials

What happened to APOTHEEK VERSCHAEVE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions